TurboFil Introduces Inline Wrap Labeler for Dual Syringe Applications

TurboFil Packaging Machines LLC, an equipment specialist dedicated solely to the design and development of liquid filling and assembly machines, has introduced a wraparound labeler that automates the often complex, labor-intensive process of dual syringe cartridge labeling. The company’s In-line Dual Syringe Labeler reliably, repeatably and accurately affixes labels around one or both cartridges in two-syringe systems.

For added versatility, TurboFil’s new machine offers both a semi-wrap mode, which wraps around one of the two cartridges, or full-wrap mode, which encircles both. The In-line Dual Syringe Labeler is designed to handle 50ml 1:1 pre-filled plastic dual-chamber syringes, such as those used in dental impression materials, restoratives and adhesives. With a maximum labeling speed of 25 meters/min, the unit can process up to 30 dual cartridges per minute.

The In-line Dual Syringe Labeler largely automates the traditionally cumbersome manual process of wraparound labeling in dual-chamber syringe settings. A single operator places syringes nose-up on the eight-foot labeling conveyor, where cartridge sensors identify them. Syringes then proceed toward the module’s servo-controlled HERMA US label applicator, where they are supported from the top with a belt. Labels are tamped on, then wrapped around one or both syringe barrels before continuing along the conveyor to a collection bin.

Given its alternating semi- and full-wrap capabilities, TurboFil’s In-line Dual Syringe Labeler can handle an especially broad range of labeling parameters. It can apply labels from 12-160mm wide, and from 12-400mm in length. Its feeder handles label rolls 300mm in diameter. An optional thermal-transfer printer also is available.

“Among other applications, dual syringes are increasingly utilized for dental products such as impression materials, restoratives, whiteners and adhesives,” said Deborah Smook, VP of Marketing & Business Development for TurboFil Packaging Machines LLC. “Solutions that streamline their production are increasingly sought-after by pharma companies looking to maximize capacity without sacrificing quality. The In-line Dual Syringe Labeler reduces the manpower required for an historically labor-intensive process down to a lone operator, allowing manufacturers to reallocate personnel to other priorities.”

SourceTurboFil

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version